The Clinical Assessment of a Inotropic Drugs

  • Barrie Levitt
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 25)


Until a few years ago, the clinical assessment of new inotropic drugs was a matter of purely academic interest. The only effective inotropic drugs available for oral use were digitalis and its derivatives and for parenteral use a number of catecholamine derivatives whose brief duration of action mandated either continuous or intermittent intravenous administration. The assessment of inotropic drugs for long term use was largely limited to experience derived from the study of digitalis materials.


Cardiac Index Pulmonary Capillary Wedge Pressure Inotropic Agent York Heart Association Class Salt Restriction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Martinus Nijhoff Publishers, Boston 1983

Authors and Affiliations

  • Barrie Levitt

There are no affiliations available

Personalised recommendations